Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours

Nature Cell Biology

Volumn 18, Issue 12, 2016, Pages 1346-1356

  Blaas, Leander ^a   Pucci, Fabio ^b   Messal, Hendrik A ^b   Andersson, Agneta B ^a   Ruiz, E Josue ^b   Gerling, Marco ^a   Douagi, Iyadh ^a   Spencer Dene, Bradley ^b   Musch, Alexandra ^a   Mitter, Richard ^b   Bhaw, Leena ^b   Stone, Richard ^b   Bornhorst, Dorothee ^a   Sesay, Abdul K ^b   Jonkers, Jos ^c   Stamp, Gordon ^b   Malanchi, Ilaria ^b   Toftgard, Rune ^a   Behrens, Axel ^b,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 6; UNCLASSIFIED DRUG; HORMONE; LGR6 PROTEIN, HUMAN; LGR6 PROTEIN, MOUSE;

ADULT; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL CARCINOMA; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INHIBITION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL LABELING; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HORMONAL REGULATION; LUMINAL BREAST TUMOR; MAMMARY GLAND PROGENITOR CELL; MOUSE; MOUSE MAMMARY TUMOR VIRUS; NONHUMAN; ONCOGENE; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; PUBERTY; STEM CELL; STEM CELL EXPANSION; ALLELE; ANIMAL; BREAST NEOPLASMS; CANCER STEM CELL; CARCINOGENESIS; CELL CLONE; CELL LINEAGE; DISEASE FREE SURVIVAL; DRUG RESISTANCE; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; HUMAN; METABOLISM; NEWBORN; PATHOLOGY; UDDER; UPREGULATION;

ALLELES; ANIMALS; ANIMALS, NEWBORN; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINEAGE; CELL PROLIFERATION; CLONE CELLS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HORMONES; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASTIC STEM CELLS; PREGNANCY; RECEPTORS, G-PROTEIN-COUPLED; STEM CELLS; UP-REGULATION;

EID: 84992692429     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3434     Document Type: Article

References (67)

1. Macias H, & Hinck L. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 1, 533-557 (2012).
2. Inman J. L, Robertson C, Mott J. D, & Bissell M. J. Mammary gland development: cell fate specification, stem cells and the microenvironment. Development 142, 1028-1042 (2015).
3. Rios A. C, Fu N. Y, Lindeman G. J, & Visvader J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506, 322-327 (2014).
4. Wang D, et al. Identification of multipotent mammary stem cells by protein C receptor expression. Nature 517, 81-84 (2015).
5. van Amerongen R, Bowman A. N, & Nusse R. Developmental stage and time dictate the fate of Wnt/-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11, 387-400 (2012).
6. Van Keymeulen A, et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189-193 (2011).
7. dos Santos C. O, et al. Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells. Proc. Natl Acad. Sci. USA 110, 7123-7130 (2013).
8. Lafkas D, et al. Notch3 marks clonogenic mammary luminal progenitor cells in vivo. J. Cell Biol. 203, 47-56 (2013).
9. Skibinski A, & Kuperwasser C. The origin of breast tumor heterogeneity. Oncogene 34, 5309-5316 (2015).
10. Shackleton M, et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006).
11. Visvader J. E, & Stingl J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 28, 1143-1158 (2014).
12. Stingl J, et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997 (2006).
13. Prater M. D, et al. Mammary stem cells have myoepithelial cell properties. Nat. Cell Biol. 16, 942-950 (2014).
14. Chang T. H, et al. New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells. Breast Cancer Res. 16, R1 (2014).
15. Wagner K. U, et al. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129, 1377-1386 (2002).
16. Ren W, et al. Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo. Proc. Natl Acad. Sci. USA 111, 16401-16406 (2014).
17. Oeztuerk-Winder F, Guinot A, Ochalek A, & Ventura J. J. Regulation of human lung alveolar multipotent cells by a novel p38 MAPK/miR-17-92 axis. Embo J. 31, 3431-3441 (2012).
18. Snippert H. J, et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385-1389 (2010).
19. Füllgrabe A, et al. Dynamics of Lgr6C progenitor cells in the hair follicle, sebaceous gland, and interfollicular epidermis. Stem Cell Rep. 5, 843-855 (2015).
20. Lim E, et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res. 12, R21 (2010).
21. Rodilla V, et al. Luminal progenitors restrict their lineage potential during mammary gland development. PLoS Biol. 13, e1002069 (2015).
22. Madisen L, et al. A robust and high-Throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133-140 (2010).
23. Kaanta A. S, Virtanen C, Selfors L. M, Brugge J. S, & Neel B. G. Evidence for a multipotent mammary progenitor with pregnancy-specific activity. Breast Cancer Res. 15, R65 (2013).
24. Prat A, Ellis M. J, & Perou C. M. Practical implications of gene-expression-based assays for breast oncologists. Nat. Rev. Clin. Oncol. 9, 48-57 (2012).
25. Goldhirsch A, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann. Oncol. 22, 1736-1747 (2011).
26. Perou C. M, et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
27. Bamford S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 91, 355-358 (2004).
28. Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
29. Scata K. A, & El-Deiry W. S. p53, BRCA1 and breast cancer chemoresistance. Adv. Exp. Med. Biol. 608, 70-86 (2007).
30. Wei G, Wang Y, Zhang P, Lu J, & Mao J. H. Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-Analysis of transcriptional profiles. J. Cancer Sci. Ther. 4, 299-305 (2012).
31. Akhoondi S, et al. Inactivation of FBXW7/hCDC4- expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Breast Cancer Res. 12, R105 (2010).
32. Wright K. L, et al. Ras signaling is a key determinant of metastatic dissemination and poor survival of luminal breast cancer patients. Cancer Res. 75, 4960-4972 (2015).
33. Wallace M. D, et al. Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. Genetics 192, 385-396 (2012).
34. Guy C. T, Cardiff R. D, & Muller W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954-961 (1992).
35. Yin Y, et al. Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling. Mol. Carcinog. 44, 42-50 (2005).
36. Oshima R, Kim S, Roopra A, & Alexander C. M. A phenotypic mouse model of basaloid breast tumors. PloS ONE 7 e30979 (2012).
37. Giraddi R. R, et al. Stem and progenitor cell division kinetics during postnatal mouse mammary gland development. Nat. Commun. 6, 8487 (2015).
38. Richert M. M, Schwertfeger K. L, Ryder J. W, & Anderson S. M. An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 5, 227-241 (2000).
39. Snippert H. J, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134-144 (2010).
40. Visvader J. E, & Clevers H. Tissue-specific designs of stem cell hierarchies. Nat. Cell Biol. 18, 349-355 (2016).
41. Wuidart A, et al. Quantitative lineage tracing strategies to resolve multipotency in tissue-specific stem cells. Genes Dev. 30, 1261-1277 (2016).
42. Shyamala G, Chou Y. C, Cardiff R. D, & Vargis E. Effect of c-neu/ ErbB2 expression levels on estrogen receptor -dependent proliferation in mammary epithelial cells: implications for breast cancer biology. Cancer Res. 66, 10391-10398 (2006).
43. Mastroianni M, et al. Wnt signaling can substitute for estrogen to induce division of ER-positive cells in a mouse mammary tumor model. Cancer Lett. 289, 23-31 (2010).
44. Arendt L. M, & Kuperwasser C. Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy. J. Mammary Gland Biol. Neoplasia 20, 9-25 (2015).
45. Boras-Granic K, Dann P, & Wysolmerski J. J. Embryonic cells contribute directly to the quiescent stem cell population in the adult mouse mammary gland. Breast Cancer Res. 16, 487 (2014).
46. Booth B. W, & Smith G. H. Estrogen receptor- And progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res. 8, R49 (2006).
47. Burga L. N, et al. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Breast Cancer Res. 13, R30 (2011).
48. Tung N, et al. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-Associated breast cancers. Breast Cancer Res. 12, R95 (2010).
49. Tung N, et al. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 12, R12 (2010).
50. Molyneux G, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
51. Joshi P. A, et al. Progesterone induces adult mammary stem cell expansion. Nature 465, 803-807 (2010).
52. Schramek D, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98-102 (2010).
53. Wagner K. U, et al. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res. 10, 545-553 (2001).
54. Malhotra G. K, et al. The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells. BMC Dev. Biol. 14 (2014).
55. Koren S, et al. PIK3CA induces multipotency and multi-lineage mammary tumours. Nature 525, 114-118 (2015).
56. Van Keymeulen A, et al. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature 525, 119-123 (2015).
57. Bao L, Cardiff R. D, Steinbach P, Messer K. S, & Ellies L. G. Multipotent luminal mammary cancer stem cells model tumor heterogeneity. Breast Cancer Res. 17, 137 (2015).
58. Chen K, Huang Y. H, & Chen J. L. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol. Sin. 34, 732-740 (2013).
59. Ciriello G, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 163, 506-519 (2015).
60. Liu X, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl Acad. Sci. USA 104, 12111-12116 (2007).
61. Jandke A, et al. The F-box protein Fbw7 is required for cerebellar development. Dev. Biol. 358, 201-212 (2011).
62. Johnson L, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001).
63. Buch T, et al. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419-426 (2005).
64. Shehata M, van Amerongen R, Zeeman A. L, Giraddi R. R, & Stingl J. The influence of tamoxifen on normal mouse mammary gland homeostasis. Breast Cancer Res. 16, 411 (2014).
65. Li B, & Dewey C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
66. Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
67. Ewald A. J, Brenot A, Duong M, Chan B. S, & Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev. Cell 14, 570-581 (2008).